Verve Therapeutics, Inc. (VERV) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 477.83M |
| Enterprise Value | 375.26M |
| P/E Ratio | -4.72 |
| PEG Ratio | -0.14 |
| Price/Sales Ratio | 30.74 |
| Price/Book Ratio | 1.91 |
| Enterprise/Revenue | 27.57 |
| Enterprise/EBITDA | -4.02 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | March 31, 2025 |
Profitability
| Profit Margin | -6.15 |
| Operating Margin | -7.07 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -0.36 |
Income Statement
| Revenue | 32.33M |
| Revenue/Share | 0.38 |
| Gross Profit | 32.33M |
| EBITDA | -221.91M |
| Net Income | -198.71M |
| Diluted EPS | -2.35 |
Balance Sheet
| Total Cash | 497.08M |
| Total Cash/Share | 6.19 |
| Total Debt | 68.64M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 12.65 |
| Book Value Per Share | 5.82 |
Price History
| 52-Week Change | 117.81 |
| 52-Week High | 11.41 |
| 52-Week Low | 2.87 |
| Moving Average 50 Days | 8.21 |
| Moving Average 200 Days | 6.45 |
Statistics
| Average Volume | 5.72M |
| Shares Outstanding | 89.31M |
| % Held by Institutions | 82.16 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
